OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.
Document Type
Article
Publication Date
8-21-2019
Publication Title
Journal of immunology (Baltimore, Md. : 1950)
Abstract
OX40 is a costimulatory molecule from the TNFR family. In mice, it is expressed on Foxp3
Clinical Institute
Cancer
Department
Earle A. Chiles Research Institute
Department
Oncology
Recommended Citation
Polesso, Fanny; Sarker, Minhaz; Weinberg, Andrew D; Murray, Susan E; and Moran, Amy E, "OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function." (2019). Articles, Abstracts, and Reports. 1971.
https://digitalcommons.providence.org/publications/1971
COinS
